Targeting N-Terminal Human Maltase-Glucoamylase to Unravel Possible Inhibitors Using Molecular Docking, Molecular Dynamics Simulations, and Adaptive Steered Molecular Dynamics Simulations

There are multiple drugs for the treatment of type 2 diabetes, including traditional sulfonylureas biguanides, glinides, thiazolidinediones, α-glucosidase inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase IV (DPP-4) inhibitors, and sodium-glucose cotransporter 2 (SG...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shitao, Wang, Yi, Han, Lu, Fu, Xueqi, Wang, Song, Li, Wannan, Han, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435576/
https://www.ncbi.nlm.nih.gov/pubmed/34527658
http://dx.doi.org/10.3389/fchem.2021.711242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435576/
https://www.ncbi.nlm.nih.gov/pubmed/34527658
http://dx.doi.org/10.3389/fchem.2021.711242

Ejemplares similares